Latham & Watkins LLP represented Icosavax, Inc. in the transaction.Icosavax, Inc. closed a US$100 million Series B Financing, led by RA Capital Management and joined by Janus…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
